| GR00053-A |
6507 |
NM_004172 |
SLC1A3 |
np |
sp |
Increased gamma-H2AX phosphorylation |
|
no |
group 4 |
Genome stability |
A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. |
Paulsen et al. |
2009 |
19647519 |
Cell line |
HeLa |
gamma-H2AX phosphorylation and DNA content |
Fluorescence |
siARRAY human genome siRNA library |
Genome-wide |
siRNA |
p-value |
Complex criteria |
Confidence groupings from 4 to 1 (highest level of confidence in group 4) |
GR00054-A |
6507 |
NM_004172 |
SLC1A3 |
np |
0.946 |
none |
|
no |
|
Combinatorial effect with paclitaxel |
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. |
Whitehurst et al. |
2007 |
17429401 |
Cell line |
NCI-H1155 |
Viability (synthetic lethal) |
ATP level |
# G-005000-01 |
Genome-wide |
siRNA |
Paclitaxel/control ratio |
Complex criteria |
Additional information about 87 high-confidence hits |
GR00056-A |
6507 |
NM_004172 |
SLC1A3 |
np |
1.054 |
none |
|
no |
|
Melanogenesis |
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. |
Ganesan et al. |
2008 |
19057677 |
Cell line |
MNT-1 |
Melanin protein expression and viability |
Absorbance and luminescence |
rp |
Genome-wide |
siRNA |
Normalized absorbance ratio |
> 2 standard deviations below mean |
Additional information about a secondary screen (retest to determine false-positive rate) |
GR00057-A-1 |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
1.93 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (1) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Z-score |
> 4 |
Screen without Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00057-A-2 |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
sp |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (2) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Complex, SP |
Complex criteria |
Screen with Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00098-A-1 |
6507 |
ENSG00000079215 |
SLC1A3 |
ENSG00000079215 |
sp |
none |
|
no |
|
Cell division (1) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Cell number and DNA content |
Laser scanning cytometry |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00147-A-1 |
6507 |
6507 |
SLC1A3 |
np |
np |
Decreased influenza A virus infection |
|
yes |
|
Influenza A virus infection (1) |
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. |
Brass et al. |
2009 |
20064371 |
Cell line |
U2OS |
Viral hemagglutinin protein surface expression |
Fluorescence |
siARRAY siRNA Library |
Genome-wide |
siRNA |
Percentage of viral hemagglutinin positive cells |
Complex criteria |
|
GR00147-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-03 |
0.99 |
none |
50 nM siRNA concentration |
no |
|
Influenza A virus infection (2) |
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. |
Brass et al. |
2009 |
20064371 |
rp |
rp |
rp |
rp |
rp |
Selected genes |
siRNA |
Percentage of infected cells |
Complex criteria |
|
GR00147-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-02 |
0.53 |
Decreased influenza A virus infection |
50 nM siRNA concentration |
no |
|
Influenza A virus infection (2) |
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. |
Brass et al. |
2009 |
20064371 |
rp |
rp |
rp |
rp |
rp |
Selected genes |
siRNA |
Percentage of infected cells |
Complex criteria |
|
GR00147-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-01 |
0.35 |
Decreased influenza A virus infection |
50 nM siRNA concentration |
no |
|
Influenza A virus infection (2) |
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. |
Brass et al. |
2009 |
20064371 |
rp |
rp |
rp |
rp |
rp |
Selected genes |
siRNA |
Percentage of infected cells |
Complex criteria |
|
GR00147-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-04 |
0.75 |
none |
50 nM siRNA concentration |
no |
|
Influenza A virus infection (2) |
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. |
Brass et al. |
2009 |
20064371 |
rp |
rp |
rp |
rp |
rp |
Selected genes |
siRNA |
Percentage of infected cells |
Complex criteria |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
14132 |
32.46 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
14132 |
-12.7 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
117230 |
-7.7 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
117230 |
-22.72 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
117231 |
np |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
117231 |
-69.36 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
119967 |
0.02 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
6507 |
6507 |
SLC1A3 |
119967 |
24.25 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00151-A-1 |
6507 |
ENSG00000079215 |
SLC1A3 |
np |
0.249 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. |
Słabicki et al. |
2010 |
20613862 |
Cell line |
HeLa |
(HR-DSBR) DR-GFP reporter |
Flow cytometry |
Custom-made |
Genome-wide |
esiRNA |
Z-score |
< -2 OR > 2 |
|
GR00165-A |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
np |
Low eccentricity cells |
|
no |
|
HeLa cell morphology |
Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. |
Fuchs et al. |
2010 |
20531400 |
Cell line |
HeLa |
Cell morphology |
Fluorescence |
siGENOME |
Genome-wide |
siRNA |
Complex, sp |
np |
|
GR00180-A-1 |
6507 |
6507 |
SLC1A3 |
PL-50050 |
0.926 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00184-A-1 |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
-0.379238907685952 |
none |
|
no |
|
Self-renewal and pluripotency in human embryonic stem cells (1) |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. |
Chia et al. |
2010 |
20953172 |
Cell line |
hESC H1 |
POU5F1 protein expression |
Fluorescence |
SMARTpool siRNA library |
Genome-wide |
siRNA |
Z-score |
< -2 |
|
GR00196-A-1 |
6507 |
ENSG00000079215 |
|
np |
sp |
none |
|
no |
|
TP53 interactions (1) |
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. |
Krastev et al. |
2011 |
21642980 |
Cell line |
HCT116 ( wildtype and TP53 knockout) |
TP53 protein expression and viability |
Fluorescence |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00197-A-1 |
6507 |
6507 |
SLC1A3 |
M-007427-00 |
0.41195234 |
none |
|
no |
|
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00221-A-1 |
6507 |
|
Slc1a3 |
TRCN0000009915 |
-0.11 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
6507 |
|
Slc1a3 |
TRCN0000009922 |
0.18 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
6507 |
|
Slc1a3 |
TRCN0000009923 |
0.7 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
6507 |
|
Slc1a3 |
TRCN0000009924 |
0.75 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
6507 |
|
Slc1a3 |
TRCN0000009914 |
0.93 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
6507 |
|
Slc1a3 |
TRCN0000009923 |
-0.04 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
6507 |
|
Slc1a3 |
TRCN0000009915 |
0 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
6507 |
|
Slc1a3 |
TRCN0000009922 |
0.55 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
6507 |
|
Slc1a3 |
TRCN0000009924 |
0.73 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
6507 |
|
Slc1a3 |
TRCN0000009914 |
1.21 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
6507 |
|
Slc1a3 |
TRCN0000009915 |
-0.75 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
6507 |
|
Slc1a3 |
TRCN0000009922 |
-0.71 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
6507 |
|
Slc1a3 |
TRCN0000009924 |
-0.68 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
6507 |
|
Slc1a3 |
TRCN0000009914 |
-0.06 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
6507 |
|
Slc1a3 |
TRCN0000009923 |
0.31 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
6507 |
|
Slc1a3 |
TRCN0000009924 |
-0.8 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
6507 |
|
Slc1a3 |
TRCN0000009923 |
-0.37 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
6507 |
|
Slc1a3 |
TRCN0000009915 |
-0.21 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
6507 |
|
Slc1a3 |
TRCN0000009922 |
-0.08 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
6507 |
|
Slc1a3 |
TRCN0000009914 |
0.19 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
|
6507 |
|
Slc1a3 |
np |
np |
Decreased viability in glioblastoma multiforme (GBM) lineage |
|
no |
GBM: no filter, two analyses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00236-A-1 |
6507 |
6507 |
SLC1A3 |
M-007427-00 |
0.858073824993411 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00240-S-1 |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
1.45 |
none |
|
yes |
|
TRAIL-induced apoptosis (1) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Z-score |
> 4 |
Author-submitted data |
GR00240-S-2 |
6507 |
NM_004172 |
SLC1A3 |
M-007427-00 |
0.61 |
none |
|
no |
Z-score 2.3155 |
TRAIL-induced apoptosis (2) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability (synthetic lethal) |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Differential score |
> 3.6 AND viability Z-score < 4 |
Author-submitted data. Z-scores from viability screen (1) are considered in score interpretation for this screen. |
GR00242-A-1 |
6507 |
NM_004172 |
SLC1A3 |
np |
sp |
Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization |
|
yes |
2/4 siRNAs confirmed |
Selective autophagy regulation (1) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
siGenome |
Genome-wide |
siRNA |
Z-score |
Complex criteria |
|
GR00242-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-01 |
5.4e-12 |
Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization |
|
yes |
|
Selective autophagy regulation (2) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-02 |
0.39 |
none |
|
yes |
|
Selective autophagy regulation (2) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-03 |
0.035 |
Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization |
|
yes |
|
Selective autophagy regulation (2) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-2 |
6507 |
6507 |
SLC1A3 |
D-007427-04 |
0.2 |
none |
|
yes |
|
Selective autophagy regulation (2) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-3 |
6507 |
6507 |
SLC1A3 |
D-007427-01 |
0.00088 |
Decreased viability after sindbis virus (SIN) dsTE12Q infection |
|
yes |
|
Selective autophagy regulation (3) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Viability |
Luminescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-3 |
6507 |
6507 |
SLC1A3 |
D-007427-02 |
0.0015 |
Decreased viability after sindbis virus (SIN) dsTE12Q infection |
|
yes |
miRNA seeds (7-8mer): 2 |
Selective autophagy regulation (3) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Viability |
Luminescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-3 |
6507 |
6507 |
SLC1A3 |
D-007427-03 |
0.0039 |
Decreased viability after sindbis virus (SIN) dsTE12Q infection |
|
yes |
|
Selective autophagy regulation (3) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Viability |
Luminescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-3 |
6507 |
6507 |
SLC1A3 |
D-007427-04 |
0.0032 |
Decreased viability after sindbis virus (SIN) dsTE12Q infection |
|
yes |
miRNA seeds (7-8mer): 1 |
Selective autophagy regulation (3) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Viability |
Luminescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-4 |
6507 |
319101 |
SLC1A3 |
D-007427-01 |
4.4e-09 |
Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
|
no |
|
Selective autophagy regulation (4) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa |
Mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-4 |
6507 |
319101 |
SLC1A3 |
D-007427-02 |
0.0013 |
Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
|
no |
miRNA seeds (7-8mer): 2 |
Selective autophagy regulation (4) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa |
Mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-4 |
6507 |
319101 |
SLC1A3 |
D-007427-03 |
0.022 |
Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
|
no |
|
Selective autophagy regulation (4) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa |
Mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00242-A-4 |
6507 |
55132 |
SLC1A3 |
D-007427-04 |
0.67 |
none |
|
no |
miRNA seeds (7-8mer): 1 |
Selective autophagy regulation (4) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa |
Mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation |
Fluorescence |
np |
Selected genes |
siRNA |
p-value |
< 0.05 |
|
GR00247-A-1 |
6507 |
|
SLC1A3 |
np |
sp |
none |
|
|
rank: 2779 |
Regulation of FOXO1 nuclear localization (1) |
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. |
Senapedis et al. |
2011 |
21460183 |
Cell line |
U2OS |
EGFP-FOXO1a protein expression and DNA content |
Fluorescence |
Human Genome library |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
|
GR00249-S |
6507 |
6507 |
SLC1A3 |
s12907 |
0.80391 |
none |
|
no |
number of cells compared to control (%): 86.59 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6507 |
6507 |
SLC1A3 |
s12908 |
-0.92516 |
none |
|
no |
number of cells compared to control (%): 86.73 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6507 |
6507 |
SLC1A3 |
s12909 |
1.07595 |
Increased vaccinia virus (VACV) infection |
|
no |
number of cells compared to control (%): 80.53 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6507 |
6507 |
SLC1A3 |
J-007427-05 |
-0.30311 |
none |
|
no |
number of cells compared to control (%): 81.60 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
6507 |
6507 |
SLC1A3 |
M-007427-00 |
-1.47997 |
none |
|
no |
number of cells compared to control (%): 50.94 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00253-A |
6507 |
NM_004172 |
SLC1A3 |
np |
0.778 |
none |
|
|
|
hepcidin regulation |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. |
Mleczko-Sanecka et al. |
2014 |
24385536 |
Cell line |
Huh7 |
hepcidin::fluc mRNA expression |
Luminescence |
siGenome siARRAY SMARTpool |
Genome-wide |
siRNA |
Z-score |
> |
Cutoff < |
GR00255-A-1 |
6507 |
6507 |
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043196, TRCN0000043197 |
0.309713066 |
none |
|
|
|
Negative genetic interactions (1) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-2 |
6507 |
6507 |
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043196, TRCN0000043197 |
-0.101354567 |
none |
|
|
|
Negative genetic interactions (2) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-3 |
6507 |
6507 |
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043196, TRCN0000043197 |
0.968540078 |
none |
|
|
|
Negative genetic interactions (3) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-4 |
6507 |
6507 |
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043196, TRCN0000043197 |
-0.225676464 |
none |
|
|
|
Negative genetic interactions (4) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-5 |
6507 |
6507 |
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043196, TRCN0000043197 |
0.00431881 |
none |
|
|
|
Negative genetic interactions (5) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -0.8 |
HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00257-A-1 |
6507 |
|
slc1a3 |
119967 |
sp |
Large nuclei |
|
|
|
Cell division, migration and survival (1) |
Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. |
Neumann et al. |
2010 |
20360735 |
Cell line |
HeLa |
H2B-GFP protein expression |
Fluorescence |
Mapped using ENSEMBL genome database version 27 |
Selected genes |
siRNA |
Complex, sp |
Complex criteria |
HeLa-H2B-GFP cells used. |
GR00293-A |
6507 |
|
SLC1A3 |
np |
-0.832 |
none |
|
|
|
Combinatorial effect with paclitaxel |
Mechanisms Promoting Escape from Mitotic Stress−Induced Tumor Cell Death |
Sinnott et al. |
2014 |
24860162 |
Cell line |
HCC366 |
Viability |
Luminescence |
Thermo-Fisher |
Genome-wide |
siRNA |
Z-score |
< -2.5 |
Final hits according to the author are indicated in the comment. |
GR00297-A |
6507 |
|
SLC1A3 |
TRCN0000043194 |
-0.14 |
none |
|
|
|
Glucose limitation response |
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
Birsoy et al. |
2014 |
24670634 |
Cell line |
Jurkat |
shRNA abundance in high and low glucose |
Deep sequencing |
TRC |
Selected genes |
shRNA |
Log2 ratio |
< -0.75 |
|
GR00297-A |
6507 |
|
SLC1A3 |
TRCN0000043196 |
-0.28 |
none |
|
|
|
Glucose limitation response |
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
Birsoy et al. |
2014 |
24670634 |
Cell line |
Jurkat |
shRNA abundance in high and low glucose |
Deep sequencing |
TRC |
Selected genes |
shRNA |
Log2 ratio |
< -0.75 |
|
GR00297-A |
6507 |
|
SLC1A3 |
TRCN0000043193 |
1.2 |
none |
|
|
|
Glucose limitation response |
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
Birsoy et al. |
2014 |
24670634 |
Cell line |
Jurkat |
shRNA abundance in high and low glucose |
Deep sequencing |
TRC |
Selected genes |
shRNA |
Log2 ratio |
< -0.75 |
|
GR00297-A |
6507 |
|
SLC1A3 |
TRCN0000043197 |
0.04 |
none |
|
|
|
Glucose limitation response |
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
Birsoy et al. |
2014 |
24670634 |
Cell line |
Jurkat |
shRNA abundance in high and low glucose |
Deep sequencing |
TRC |
Selected genes |
shRNA |
Log2 ratio |
< -0.75 |
|
GR00297-A |
6507 |
|
SLC1A3 |
TRCN0000043195 |
0.69 |
none |
|
|
|
Glucose limitation response |
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
Birsoy et al. |
2014 |
24670634 |
Cell line |
Jurkat |
shRNA abundance in high and low glucose |
Deep sequencing |
TRC |
Selected genes |
shRNA |
Log2 ratio |
< -0.75 |
|
GR00300-A |
6507 |
|
SLC1A3 |
TRCN0000043193, TRCN0000043194, TRCN0000043197, TRCN0000043196 |
1 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
GR00300-A |
6507 |
|
Slc1a3 |
TRCN0000009923, TRCN0000009924, TRCN0000009922, TRCN0000009915, TRCN0000009914 |
0 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
GR00303-A |
6507 |
NM_004172 |
SLC1A3 |
np |
0.88 |
none |
|
|
|
Clear cell renal cell carcinoma (ccRCC) survival regulation |
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
Gerlinger et al. |
2012 |
22362593 |
Cell line |
VHL-deficient RCC4 |
Proliferation and Viability |
Fluorescence |
np |
Genome-wide |
siRNA |
Z-score |
< |
In the phenotype data duplicates were in the original document, which have been removed. |
GR00310-A-1 |
6507 |
6507 |
SLC1A3 |
np |
0.08 |
none |
|
|
|
Sindbis virus (SINV) infection (1) |
Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry |
Ooi et al. |
2013 |
24367265 |
Cell line |
U2OS |
Sindbis virus (SINV) reporter |
Luminescence |
Ambion Silencer V3 |
Genome-wide |
siRNA |
Z-score |
< -3 OR > 2 |
|
|
6507 |
6507 |
SLC1A3 |
np |
72.8 |
Inconclusive |
|
|
60,3% viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00313-A |
6507 |
NM_004172 |
SLC1A3 |
np |
-0.3 |
none |
|
|
|
TNF-alpha pathway regulation |
A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. |
Nickles et al. |
2012 |
22733992 |
Cell line |
HEK293T |
NFkappaB pathway reporter |
Luminescence |
Qiagen |
Genome-wide |
siRNA |
Z-score |
< |
Additional filters were a reduction in firefly luciferase levels by at least 50% compared to the mean of the experiment and a concomitant reduction of renilla luciferase expression of not more than 30%. |
GR00343-S |
6507 |
6507 |
SLC1A3 |
TRCN0000043197 |
-1.2925000000000004 |
shRNA abundance <= 50% |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
20512 |
Slc1a3 |
TRCN0000009914 |
0.3424999999999976 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
20512 |
Slc1a3 |
TRCN0000009924 |
0.10250000000000092 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
20512 |
Slc1a3 |
TRCN0000009923 |
0.6624999999999996 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
6507 |
SLC1A3 |
TRCN0000043194 |
0.7275000000000009 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
20512 |
Slc1a3 |
TRCN0000009922 |
-0.9350000000000005 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
6507 |
SLC1A3 |
TRCN0000043196 |
1.0399999999999991 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
6507 |
SLC1A3 |
TRCN0000043193 |
-2.4949999999999974 |
shRNA abundance <= 25% |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
6507 |
20512 |
Slc1a3 |
TRCN0000009915 |
-0.13250000000000028 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00363-A |
6507 |
6507 |
SLC1A3 |
117231, 117230, SI00721021, esi1433, SI00721007, SI00721014, SI00721028, 119967 |
sp |
Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis |
|
|
strong |
Endocytosis regulation |
Systems survey of endocytosis by multiparametric image analysis. |
Collinet et al. |
2010 |
20190736 |
Cell line |
HeLa |
Transferrin (TF) and epidermal growth factor (EGF) subcellular localisation, DNA content |
Fluorescence |
Ambion, Qiagen and esiRNA library (Kittler et al.) |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
Two hit categories: "strong" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn > 0.95) and "weak but specific" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn < 0.95 but Phenoscore > 0.95). Additional information about secondary screens with kinase and phospatase libraries. |
GR00368-A |
6507 |
6507 |
SLC1A3 |
|
0.66 |
Decreased viability ratio |
|
|
wt viability: 0,56 |
Combinatorial effect with E-Cadherin |
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin–Deficient Cells |
Telford et al. |
2015 |
25777964 |
Cell line |
MCF10A |
Viability (synthetic lethal) |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
CDH1(-/-)/wt viability ratio |
< |
MCF10A wild type viability higher-or-equal to 50% was considered as additional cutoff (values noted in "comment" section). |
|
6507 |
6507 |
SLC1A3 |
|
0 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00376-A-1 |
6507 |
6507 |
SLC1A3 |
|
0.633914934 |
none |
|
|
|
Mitigators of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID |
GR00376-A-2 |
6507 |
6507 |
SLC1A3 |
|
0.285056329 |
none |
|
|
|
Sensitizers of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID |
GR00378-A |
6507 |
|
SLC1A3 |
|
0.086406251 |
none |
|
|
|
Poliovirus vaccine production |
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game |
van der Sanden et al. |
2015 |
26581994 |
Cell line |
HEp-2C |
Infection with Attenuated Poliovirus |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Z-score |
> |
For infection, a single lot of the attenuated Sabin type 2 poliovirus was used for the screen. Gene IDs were not provided, only the gene name/symbol |
|
6507 |
NM_004172 |
SLC1A3 |
|
51.601 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00381-A-2 |
6507 |
|
SLC1A3 |
|
32.189956041028374 |
none |
|
|
Plasma Membrane; |
Regulation of mammary epithelial cell growth (2) |
A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation. |
Burleigh et al. |
2015 |
25572802 |
Cell line |
184-hTERT-L9 (mammary epithelial cells) |
Viability |
Count |
Dharmacon siGENOME |
Selected genes |
siRNA |
Percent growth |
< 25 % AND p-value < 0.05 |
388 genes from screen (1) showing <25% growth and suspected or confirmed to be present in transmembrane or extracellular space, and secreted proteins were selected for this secondary screening. Not all of the final hits are represented since more data was taken into account for the final selection. For reagents information check screen (1) |
GR00381-A-3 |
6507 |
|
SLC1A3 |
|
28.663793103448278 |
none |
|
|
Plasma Membrane; |
Regulation of mammary epithelial cell growth (3) |
A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation. |
Burleigh et al. |
2015 |
25572802 |
Cell line |
184-hTERT-E11 (mammary epithelial cells) |
Viability |
Count |
Dharmacon siGENOME |
Selected genes |
siRNA |
Percent growth |
< 25 % AND p-value < 0.05 |
184-hTERT-E11 differs from 184-hTERT-L9 only in the position of hTERT insertion. 388 genes from screen (1) showing <25% growth and suspected or confirmed to be present in transmembrane or extracellular space, and secreted proteins were selected for this secondary screening. Not all of the final hits are represented since more data was taken into account for the final selection. For reagents information check screen (1) |
GR00386-A-1 |
6507 |
6507 |
SLC1A3 |
|
58.3354483733831 |
Decreased viability |
|
|
|
NOD2 stimulation by MDP |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
Viability |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
Percentage growth |
Decreased: <70, increased: >120 |
Reagent IDs not provided |
GR00386-A-2 |
6507 |
6507 |
SLC1A3 |
|
6.8 |
none |
|
|
|
MDP-induced IL-8 secretion |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
IL-8 secretion |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Percent inhibition of IL-8 secretion |
Increased: <-300, Decreased: >60 |
Concentration of IL-8 was measured from cell supernatants by sandwich ELISA. IL-8 values (pg/ml) were normalized to IL-8 secreted in cells treated with RIPK2-specific siRNA (100% inhibition) and non-targeting siRNA (0% inhibition). Secondary validating screen assessed 554 genes whose silencing affected MDP-induced IL-8 secretion in the primary screen. Final validated IL-8 regulators (positive or negative) are listed in the comments column. Reagent IDs not provided |